Our experiences on endovascular and hybrid treatment of peripheral arterial diseases

All patients were discharged within 1 to 16 days.Conclusion: Endovascular and hybrid modalities are safe and comfortable in the treatment of peripheral arterial diseases for vascular surgeons having a hybrid room.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background: This study aims to present our experiences on endovascular and hybrid treatment of peripheral arterial diseases.Methods: Between March 2008 and April 2016, 86 patients who underwent endovascular treatment and 17 patients who underwent hybrid treatment for peripheral arterial disease in our clinic were retrospectively analyzed.

📊

Key Findings & Data:Anticoagulation was maintained with low-molecular-weighted heparin for three days, followed by dual oral antiaggregant (acetylsalicylic acid 100 mg + clopidogrel 75 mg).

💡

Conclusion & Impact:All patients were discharged within 1 to 16 days.Conclusion: Endovascular and hybrid modalities are safe and comfortable in the treatment of peripheral arterial diseases for vascular surgeons having a hybrid room.

🔬Design:Research Article

📍Scope:2008 Verileri

⚙️Variables:Domain Parameters

Abstract

Background: This study aims to present our experiences on endovascular and hybrid treatment of peripheral arterial diseases.Methods: Between March 2008 and April 2016, 86 patients who underwent endovascular treatment and 17 patients who underwent hybrid treatment for peripheral arterial disease in our clinic were retrospectively analyzed. The treatment approaches, success of treatments, complications and outcomes of these patients were studied.Results: No mortality was seen during the procedures. Following the procedure, the patients were hospitalized in the intensive care unit under standard heparin treatment for six hours at least. Anticoagulation was maintained with low-molecular-weighted heparin for three days, followed by dual oral antiaggregant (acetylsalicylic acid 100 mg + clopidogrel 75 mg). Repeated Doppler ultrasonography revealed no in-stent thrombosis or restenosis at the site of ballooning during hospitalization. None of the patients with normal renal functions preoperatively experienced severe renal failure. Although nearly all femorodistal interventions were performed in the antegrade way, none of the patients had bleeding complications at the site of intervention. All patients were discharged within 1 to 16 days.Conclusion: Endovascular and hybrid modalities are safe and comfortable in the treatment of peripheral arterial diseases for vascular surgeons having a hybrid room.

Özet

Amaç: Bu çalışmada, periferik arter hastalıklarının endovasküler ve hibrid yaklaşım ile tedavisinde edindiğimiz deneyimler sunuldu. Çalışma planı: Mart 2008 - Nisan 2016 tarihleri arasında periferik arter hastalığı nedeniyle kliniğimizde endovasküler tedavi yapılan 86 hasta ve hibrid tedavi yapılan 17 hasta retrospektif olarak incelendi. Tedavi yaklaşımları, tedavi başarıları, komplikasyonları ve prognozları değerlendirildi. Bulgular: İşlemler sırasında mortalite görülmedi. İşlem sonrası hastalar standart heparin tedavisi altında en az altı saat yoğun bakım ünitesinde kaldı. Üç gün düşük molekül ağırlıklı heparin ile antikoagülasyonu takiben ikili oral antiagregan (100 mg asetilsalisilikasit + 75 mg klopidogrel) başlandı. Kontrol Doppler ultrasonografide hastanede yatış süresince stent içi tromboz veya balon uygulanan bölgede restenoza rastlanmadı. Ameliyat öncesi böbrek fonksiyonları normal olan hastaların hiçbirinde ciddi böbrek yetmezliği gelişmedi. Femorodistal girişimlerin neredeyse tamamında antegrad yol kullanılmasına rağmen, hiçbir hastanın girişim yerinde kanama komplikasyonu görülmedi. Hastaların tümü 1 ila 16 günde taburcu edildi. Sonuç: Endovasküler ve hibrid yöntemler; periferik arter hastalıklarının tedavisinde, hibrid salonu bulunan damar cerrahları için güvenli ve konforludur.

🔖

Cite This Article

YILMAZ, A. T., UĞUR, M., TEMİZKAN, V., KARDEŞOĞLU, E., CAN, M. F., UÇAK, A., ALP, İ., SELÇUK, A. (2022). Our experiences on endovascular and hybrid treatment of peripheral arterial diseases. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 26 - Sayı: 2, 237–245. https://ajindex.com/articles/423843

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (11)

Badak TO, Uncu H, Uçak HA, Samsa Z, Özsöyler İ. Greft trombozuna hibrid cerrahi yaklaşımı. Turk Gogus Kalp Dama 2015;23:744-7
Uğur M, Alp İ, Arslan G, Şenay Ş, Selçuk İ, Selçuk A ve ark. Vasküler hastalıkların yönetiminde endovasküler ve hibrid uygulamalar: Kardiyovasküler cerrahi kliniği deneyimleri. Turk Gogus Kalp Dama 2012;20:230-42
New G, Roubin GS, Iyer SS, Vitek JJ, Moussa I, Al-Mubarak N, et al. Integrated minimally invasive approaches for the treatment of atherosclerotic vascular diseases: Hybrid procedures. Catheter Cardiovasc Interv 2001;52:154- 61
White R, Krajcer Z, Johnson M, Williams D, Bacharach M, O'Malley E. Results of a multicenter trial for the treatment of traumatic vascular injury with a covered stent. J Trauma 2006;60:1189-95
Schneider PA, Caps MT, Ogawa DY, Hayman ES. Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal bypass graft: an option for combined open and endovascular treatment of diabetic gangrene. J Vasc Surg 2001;33:955-62
Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002;252:225 -32
Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA 1995;274:165-71
Balaz P, Rokosny S, Wohlfahrt P, Adamec M, Janousek L, Björck M. Early and late outcomes of hybrid endovascular and open repair procedures in patients with peripheral arterial disease. Vasa 2013;42:292 -300
Dosluoglu HH, Lall P, Cherr GS, Harris LM, Dryjski ML. Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease. J Vasc Surg 2010;51:1425-35
Ebaugh JL, Gagnon D, Owens CD, Conte MS, Raffetto JD. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg 2008;196:634-40
Schrijver AM, Moll FL, De Vries JP. Hybrid procedures for peripheral obstructive disease. J Cardiovasc Surg (Torino) 2010;51:833-43.